Clinical Trial Update: Effect of Avastin in Juxtafoveal Telangiectasias [Phase 3]

View source ↗

Summary

This Phase 3 trial of bevacizumab (Avastin) for juxtafoveal telangiectasia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juxtafoveal Telangiectasia

Drugs mentioned

• Avastin (bevacizumab)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Telangiectasis | Phase 3 | Status: WITHDRAWN